Literature DB >> 11751857

Estradiol-induced nongenomic calcium signaling regulates genotropic signaling in macrophages.

Zhiyong Guo1, Jurgen Krucken, W Peter M Benten, Frank Wunderlich.   

Abstract

Estradiol (E(2)) exerts not only genotropic but also nongenomic actions through nuclear estrogen receptors (ER). Here, we provide a novel paradigm for nongenomic E(2) signaling independent of nuclear ER. E(2) induces a rapid rise in the intracellular free Ca(2+) concentration ([Ca(2+)](i)) through membrane estrogen receptors in murine RAW 264.7 macrophages. This E(2)-induced Ca(2+) signaling is not prevented by different ER blockers and cannot directly activate stably transfected c-fos promoter or the mitogen-activated protein kinases p38, ERK1/2, and SAPK/JNK, or NO production. However, the E(2)-induced rise in [Ca(2+)](i) specifically down-regulates the serum-stimulated activation of c-fos promoter and ERK1/2, and conversely, it specifically up-regulates lipopolysaccharide-stimulated activation of c-fos promoter, p38, and NO production. The E(2)-changed activation of c-fos promoter can be prevented by an intracellular Ca(2+) chelator. Our data indicate that E(2)-induced nongenomic Ca(2+) signaling through membrane ER is able to specifically modulate genotropic signaling pathways with impact on macrophage activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751857     DOI: 10.1074/jbc.M109808200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Mitogen activated protein kinase (MAPK) mediates non-genomic pathway of estrogen on T cell cytokine production following trauma-hemorrhage.

Authors:  Takao Suzuki; Huang-Ping Yu; Ya-Ching Hsieh; Mashkoor A Choudhry; Kirby I Bland; Irshad H Chaudry
Journal:  Cytokine       Date:  2008-03-14       Impact factor: 3.861

2.  Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis.

Authors:  Eric Blasko; Christopher A Haskell; Stewart Leung; Giovanna Gualtieri; Meredith Halks-Miller; Mithra Mahmoudi; Megan K Dennis; Eric R Prossnitz; William J Karpus; Richard Horuk
Journal:  J Neuroimmunol       Date:  2009-08-06       Impact factor: 3.478

3.  Estrogen Receptors in Regulating Cell Proliferation of Esophageal Squamous Cell Carcinoma: Involvement of Intracellular Ca2+ Signaling.

Authors:  Zhe Zhang; Qinsi He; Si Fu; Zhi Zheng
Journal:  Pathol Oncol Res       Date:  2016-09-05       Impact factor: 3.201

4.  17-Beta estradiol enhances prostaglandin E2 production in human U937-derived macrophages.

Authors:  Biao Lu; Yan J Jiang; Patrick C Choy
Journal:  Mol Cell Biochem       Date:  2004-07       Impact factor: 3.396

Review 5.  The role of estrogen and receptor agonists in maintaining organ function after trauma-hemorrhage.

Authors:  Huang-Ping Yu; Irshad H Chaudry
Journal:  Shock       Date:  2009-03       Impact factor: 3.454

Review 6.  Non-nuclear actions of estrogen: new targets for prevention and treatment of cardiovascular disease.

Authors:  Karen J Ho; James K Liao
Journal:  Mol Interv       Date:  2002-07

7.  Estrogenic compounds suppressed interferon-gamma production in mouse splenocytes through direct cell-cell interaction.

Authors:  Mako Nakaya; Masao Yamasaki; Yoshiyuki Miyazaki; Hirofumi Tachibana; Koji Yamada
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Sep-Oct       Impact factor: 2.416

8.  The membrane actions of estrogens can potentiate their lordosis behavior-facilitating genomic actions.

Authors:  Lee-Ming Kow; Donald W Pfaff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-09       Impact factor: 11.205

9.  The PI3K/Akt pathway mediates the nongenomic cardioprotective effects of estrogen following trauma-hemorrhage.

Authors:  Huang-Ping Yu; Ya-Ching Hsieh; Takao Suzuki; Mashkoor A Choudhry; Martin G Schwacha; Kirby I Bland; Irshad H Chaudry
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

Review 10.  Gender and sex hormones in multiple sclerosis pathology and therapy.

Authors:  Arnaud Nicot
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.